<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0200269.ref042">
 <label>42</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Fried</surname>
   <given-names>MW</given-names>
  </name>, 
  <name>
   <surname>Shiffman</surname>
   <given-names>ML</given-names>
  </name>, 
  <name>
   <surname>Reddy</surname>
   <given-names>KR</given-names>
  </name>, 
  <name>
   <surname>Smith</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Marinos</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Goncales</surname>
   <given-names>FL</given-names>
   <suffix>Jr.</suffix>
  </name>, 
  <etal>et al</etal>
  <article-title>Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</article-title>. 
  <source>N Engl J Med</source>. 
  <year>2002</year>;
  <volume>347</volume>(
  <issue>13</issue>):
  <fpage>975</fpage>â€“
  <lpage>82</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa020047</pub-id> .
  <?supplied-pmid 12324553?>
  <pub-id pub-id-type="pmid">12324553</pub-id>
 </mixed-citation>
</ref>
